HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Recent studies have shown that HSD17B13, a member of the 17β-hydroxysteroid dehydrogenase family, plays a critical role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) 38, indicating a role of this family in regulating hepatic lipid metabolism.